Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Wellcip-750
Wellcip-750 offers ciprofloxacin in 750 mg tablets, formulated to treat severe bacterial infections effectively.
Uses of Wellcip-750
Wellcip-750 is indicated for:
Treatment of complicated urinary tract infections
Treatment of respiratory tract infections, including pneumonia
Treatment of skin and soft tissue infections
Treatment of bone and joint infections
Benefits of Wellcip-750
Potent antibacterial activity against a broad spectrum of bacteria
Rapid onset of action
High bioavailability with convenient dosing
Mechanism of Action of Wellcip-750
Ciprofloxacin in Wellcip-750 inhibits bacterial DNA gyrase and topoisomerase IV enzymes, essential for bacterial DNA replication, transcription, repair, and recombination. This mechanism leads to bacterial cell death and eradication of the infection.